Metropolitan Life Insurance Company (MetLife)’s Resideo Technologies REZI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,694
Closed -$172K 1666
2024
Q1
$172K Sell
7,694
-738
-9% -$14.6K 0.01% 777
2023
Q4
$159K Hold
8,432
0.01% 854
2023
Q3
$133K Buy
8,432
+507
+6% +$8.53K 0.01% 871
2023
Q2
$140K Buy
7,925
+260
+3% +$4.49K 0.01% 844
2023
Q1
$140K Sell
7,665
-1,402
-15% -$25.4K 0.01% 825
2022
Q4
$149K Hold
9,067
0.01% 851
2022
Q3
$173K Hold
9,067
0.01% 730
2022
Q2
$176K Hold
9,067
0.01% 749
2022
Q1
$216K Sell
9,067
-28,189
-76% -$707K 0.01% 780
2021
Q4
$970K Sell
37,256
-574
-2% -$14.9K 0.01% 986
2021
Q3
$938K Sell
37,830
-1,697
-4% -$49.4K 0.01% 1008
2021
Q2
$1.19M Buy
39,527
+283
+0.7% +$8.38K 0.02% 880
2021
Q1
$1.11M Sell
39,244
-970
-2% -$25.6K 0.02% 871
2020
Q4
$855K Buy
40,214
+4,647
+13% +$74.4K 0.01% 988
2020
Q3
$391K Sell
35,567
-2,590
-7% -$32.8K 0.01% 1375
2020
Q2
$447K Buy
38,157
+5,447
+17% +$37.9K 0.01% 1294
2020
Q1
$158K Sell
32,710
-1,776
-5% -$16.8K ﹤0.01% 1731
2019
Q4
$411K Buy
34,486
+220
+0.6% +$2.5K 0.01% 1450
2019
Q3
$492K Sell
34,266
-4,594
-12% -$77K 0.01% 1306
2019
Q2
$852K Sell
38,860
-192
-0.5% -$4.06K 0.01% 991
2019
Q1
$753K Sell
39,052
-236
-0.6% -$5.23K 0.01% 1044
2018
Q4
$807K Buy
+39,288
New +$839K 0.02% 925

Other funds holding REZI

Metropolitan Life Insurance Company (MetLife)'s REZI Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Resideo Technologies (REZI) in Q2 2024, closing a stake of 7,694 shares — an estimated $172K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in REZI in Q4 2018 and held it in 22 quarters. The position peaked at $1.19M in Q2 2021. 402 funds tracked by Wall St. Rank hold REZI as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Resideo Technologies position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 7,694 Resideo Technologies shares in Q2 2024, an estimated $172K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Resideo Technologies in Q4 2018 and held it in 22 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Resideo Technologies position peaked at $1.19M in Q2 2021.
  • 402 funds tracked by Wall St. Rank held Resideo Technologies as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.